Ulcerative Colitis Clinical Trials

Showing 8141-8160 of 9,572 trials

UNKNOWNNA

Acute Effects of a Stretching Program of the Rib Cage Muscles on Patients With COPD During Exercise

NCT02383277

Investigate the effects of stretching the muscles of the rib cage in individuals with COPD during exercise.

Pulmonary Disease, Chronic Obstructive

Universidade Federal de Pernambuco20 participantsStarted Nov 2014

COMPLETEDPhase 4

Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin America

NCT01518244

The purpose of this study was to assess the efficacy and tolerability of changing to AZARGA® from prior COMBIGAN® pharmacotherapy in participants with open-angle glaucoma or ocular hypertension.

Glaucoma

Alcon Research50 participantsStarted Dec 2011

COMPLETED

Diagnosis of Mucopolysaccharidosis Disorders in Patients Presenting With Bilateral Hip Disease

NCT01707433

BACKGROUND/OBJECTIVE: Quantitative urine screening for mucopolysaccharides (MPS) has been the primary method for detecting mucopolysaccharidoses in children. This method may not be sufficiently sensitive and may miss some patients with arylsulfatase B (ARSB) deficiency. Investigators propose to identify patients retrospectively and prospectively who carry a diagnosis of spondyloepiphyseal dysplasia, multiple epiphyseal dysplasia, bilateral proximal femoral epiphyseal dysplasia, or bilateral Legg-Calve-Perthes. For these patients, investigators will perform enzyme testing on a blood sample which will identify MPS VI or IVA. Patients who have an earlier diagnosis of MPS are likely to have better health outcomes with medical management. Therefore, it is important to determine effective diagnostic methods. Investigators believe that bilateral hip involvement should alert the clinician to the possibility of MPS VI and further examination. The purpose of this study is to test the hypothesis that the correct diagnoses of two MPS storage disorders are delayed in patients with bilateral proximal femoral epiphyseal dysplasia and normal quantitative urine MPS studies.

Mucopolysaccharidosis IV AMucopolysaccharidosis VI

Children's Hospitals and Clinics of Minnesota22 participantsStarted Oct 2012

Minneapolis, Minnesota, United States • Saint Paul, Minnesota, United States

Acute Effects of a Stretching Program of the Rib Cage Muscles on Patients With COPD During Exercise

Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin America

Diagnosis of Mucopolysaccharidosis Disorders in Patients Presenting With Bilateral Hip Disease

Related Searches

Accuracy of Spybite Forceps When Compared to Conventional Sampling Methods

Effectiveness Study of Teacher Training and Social and Financial Education in Rwanda's Primary and Secondary Schools

Obstructed Defaecation: Proctography Versus Ultrasound in Symptomatic Patients

Genetic Polymorphisms Predict Chemotherapeutic Outcomes in Patients With Metastatic Breast Cancer

Ventilation-drive Coupling to Evaluate The Efficacy of Inhaled Bronchodilators in Patients With COPD

Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer

Lipid Use, Nutrition, and Colitis in Patients With Hematological Malignancies

Sarizotan in the Treatment of Neuroleptic-induced Tardive Dyskinesia

Telemonitoring of Patients With COPD in Carinthia

A Mobile-health Pilot Experiment Targeting Mothers With Newborns in Rural Areas of San Juan Sacatepequez, Guatemala

Effect of Zopiclone on Compliance With Continuous Positive Airway Pressure in Obstructive Sleep Apnea

Use of Corifolitropin Alfa in Oocyte Donors

Non-invasive Positive Pressure (NPPV ) for Severe Stable Chronic Obstructive Pulmonary Disease

Nitric Oxyde Concentration in Chronic Obstructive Pulmonary Disease Patients - SANOB Study

DE-111 Against Timolol Ophthalmic Solution 0.5%

The Effect of Omega-3 Fatty Acid Supplementation on Intraocular Pressure & Ocular Surface

A Phase 1 Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS 9411 in Subjects With Cystic Fibrosis (CF)